ICU Medical (NASDAQ:ICUI) will be posting its quarterly earnings results after the market closes on Wednesday, August 7th. Analysts expect ICU Medical to post earnings of $1.86 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.39. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The firm had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. During the same period last year, the company earned $2.26 earnings per share. The business’s revenue for the quarter was down 11.0% on a year-over-year basis. On average, analysts expect ICU Medical to post $9 EPS for the current fiscal year and $9 EPS for the next fiscal year.
ICU Medical stock opened at $247.46 on Tuesday. ICU Medical has a one year low of $210.94 and a one year high of $321.70. The stock has a fifty day moving average of $250.17. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 32.10 and a beta of 0.81.
A number of equities analysts have recently commented on the company. TheStreet raised ICU Medical from a “c+” rating to a “b” rating in a report on Friday, May 10th. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday, July 25th. Finally, BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company’s stock. ICU Medical currently has an average rating of “Buy” and a consensus price target of $290.50.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: What is systematic risk?
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.